CY1799A - Orthorhombic ciclosporin crystal form process for its production and pharmaceutical compositions containing it - Google Patents
Orthorhombic ciclosporin crystal form process for its production and pharmaceutical compositions containing itInfo
- Publication number
- CY1799A CY1799A CY179995A CY179995A CY1799A CY 1799 A CY1799 A CY 1799A CY 179995 A CY179995 A CY 179995A CY 179995 A CY179995 A CY 179995A CY 1799 A CY1799 A CY 1799A
- Authority
- CY
- Cyprus
- Prior art keywords
- ciclosporin
- orthorhombic
- production
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13623087A | 1987-12-21 | 1987-12-21 | |
| US17261388A | 1988-03-24 | 1988-03-24 | |
| US21254888A | 1988-06-28 | 1988-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1799A true CY1799A (en) | 1995-02-17 |
Family
ID=27384838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY179995A CY1799A (en) | 1987-12-21 | 1995-02-17 | Orthorhombic ciclosporin crystal form process for its production and pharmaceutical compositions containing it |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPH0791316B2 (en) |
| KR (1) | KR100188305B1 (en) |
| AT (1) | AT403163B (en) |
| AU (1) | AU626274B2 (en) |
| BE (1) | BE1002665A4 (en) |
| CA (1) | CA1341396C (en) |
| CH (1) | CH677926A5 (en) |
| CY (1) | CY1799A (en) |
| DE (1) | DE3843054C2 (en) |
| DK (1) | DK175220B1 (en) |
| ES (1) | ES2012580A6 (en) |
| FI (1) | FI89065C (en) |
| FR (1) | FR2624863B1 (en) |
| GB (1) | GB2211848B (en) |
| GR (1) | GR1002486B (en) |
| HK (1) | HK102894A (en) |
| HU (1) | HU203564B (en) |
| IE (1) | IE62006B1 (en) |
| IL (1) | IL88719A0 (en) |
| IT (1) | IT1235356B (en) |
| LU (1) | LU87409A1 (en) |
| MY (1) | MY103943A (en) |
| NL (1) | NL195096C (en) |
| NO (1) | NO177228C (en) |
| NZ (1) | NZ227384A (en) |
| SE (1) | SE503174C2 (en) |
| SG (1) | SG99494G (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639724A (en) * | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
| KR0148748B1 (en) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | A multiphase cyclosporin composition |
| US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
| US7081445B2 (en) | 1989-02-20 | 2006-07-25 | Novartis Ag | Cyclosporin galenic forms |
| US5294604A (en) * | 1989-12-20 | 1994-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating ocular diseases by periocular administration of cyclosporine A or G |
| GB9105705D0 (en) * | 1991-03-18 | 1991-05-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| SG45449A1 (en) * | 1992-05-13 | 1998-01-16 | Sandoz Ltd | Ophthalmic compositions |
| PT589843E (en) | 1992-09-25 | 2002-04-29 | Novartis Ag | PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS |
| PT789580E (en) | 1994-11-03 | 2002-09-30 | Novartis Ag | CYCLOSPORINE FORMULATIONS FOR ORAL ADMINISTRATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY AND PROCESS FOR ITS PRODUCTION |
| US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| DE19544507B4 (en) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin containing preparations |
| US6262054B1 (en) * | 1996-02-01 | 2001-07-17 | Sloan-Kettering Institute Of Cancer Research | Combination therapy method for treating breast cancer using edatrexate |
| RU2211047C2 (en) | 1997-01-30 | 2003-08-27 | Новартис Аг | Gelatin capsule with solid film including oil-free pharmaceutically compositions |
| TW581681B (en) | 1998-02-20 | 2004-04-01 | Nektar Therapeutics | Liquid crystal forms of cyclosporin |
| US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| DE602005011928D1 (en) | 2004-01-20 | 2009-02-05 | Allergan Inc | COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, PREFERABLY CONTAINING TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID |
| CN1763084B (en) * | 2005-10-11 | 2010-04-21 | 山东新时代药业有限公司 | High purity cyclosporin A preparation method |
| BR112013030554B1 (en) | 2011-05-27 | 2020-12-15 | Allergan, Inc. | CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION AND METHODS FOR USE OF THE SAME |
| CN104080442B (en) | 2011-11-15 | 2018-01-05 | 阿勒根公司 | The suspension of cyclosporin A form 2 |
| KR102072252B1 (en) | 2011-11-15 | 2020-01-31 | 알러간, 인코포레이티드 | Cyclosporin a form 2 and method of making same |
| ES2675269T3 (en) * | 2011-11-15 | 2018-07-10 | Allergan, Inc. | Treatable autoclavable suspensions of cyclosporin A form 2 |
| CN108175742B (en) | 2011-11-15 | 2021-10-22 | 阿勒根公司 | Sustained action formulation of cyclosporin form 2 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH614931A5 (en) * | 1975-11-04 | 1979-12-28 | Sandoz Ag | |
| CH640519A5 (en) * | 1976-04-09 | 1984-01-13 | Sandoz Ag | Process for preparing a modified form of the antibiotic S 7481/F-1 |
| US4117118A (en) * | 1976-04-09 | 1978-09-26 | Sandoz Ltd. | Organic compounds |
| DE2819094A1 (en) * | 1977-05-10 | 1978-11-23 | Sandoz Ag | CYCLOSPORIN DERIVATIVES, THEIR USE AND MANUFACTURING |
| CH637124A5 (en) * | 1978-10-18 | 1983-07-15 | Sandoz Ag | Antibiotic, its preparation and use |
-
1988
- 1988-12-09 HU HU886374A patent/HU203564B/en unknown
- 1988-12-19 CH CH4687/88A patent/CH677926A5/de not_active IP Right Cessation
- 1988-12-19 NZ NZ227384A patent/NZ227384A/en unknown
- 1988-12-19 FI FI885869A patent/FI89065C/en not_active IP Right Cessation
- 1988-12-19 AU AU27055/88A patent/AU626274B2/en not_active Expired
- 1988-12-19 IL IL88719A patent/IL88719A0/en unknown
- 1988-12-19 GB GB8829556A patent/GB2211848B/en not_active Expired - Lifetime
- 1988-12-19 IE IE377988A patent/IE62006B1/en not_active IP Right Cessation
- 1988-12-19 FR FR888816886A patent/FR2624863B1/en not_active Expired - Lifetime
- 1988-12-19 SE SE8804570A patent/SE503174C2/en not_active IP Right Cessation
- 1988-12-19 DK DK198807054A patent/DK175220B1/en not_active IP Right Cessation
- 1988-12-19 NO NO885625A patent/NO177228C/en unknown
- 1988-12-20 KR KR1019880017194A patent/KR100188305B1/en not_active IP Right Cessation
- 1988-12-20 LU LU87409A patent/LU87409A1/en unknown
- 1988-12-20 BE BE8801421A patent/BE1002665A4/en not_active IP Right Cessation
- 1988-12-20 IT IT8848690A patent/IT1235356B/en active
- 1988-12-20 AT AT0309588A patent/AT403163B/en not_active IP Right Cessation
- 1988-12-20 GR GR880100850A patent/GR1002486B/en not_active IP Right Cessation
- 1988-12-20 JP JP63321857A patent/JPH0791316B2/en not_active Expired - Lifetime
- 1988-12-21 MY MYPI88001495A patent/MY103943A/en unknown
- 1988-12-21 ES ES8803887A patent/ES2012580A6/en not_active Expired - Lifetime
- 1988-12-21 CA CA000586611A patent/CA1341396C/en not_active Expired - Fee Related
- 1988-12-21 NL NL8803125A patent/NL195096C/en active Search and Examination
- 1988-12-21 DE DE3843054A patent/DE3843054C2/en not_active Expired - Lifetime
-
1994
- 1994-07-21 SG SG99494A patent/SG99494G/en unknown
- 1994-09-22 HK HK102894A patent/HK102894A/en not_active IP Right Cessation
-
1995
- 1995-02-17 CY CY179995A patent/CY1799A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1799A (en) | Orthorhombic ciclosporin crystal form process for its production and pharmaceutical compositions containing it | |
| HUT45954A (en) | Process for producing tetrahydronaphtalene- and indanederivatives and pharmaceutical compositions containing them | |
| HUT48900A (en) | Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them | |
| HUT53644A (en) | Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them | |
| HUT48267A (en) | Process for producing fluoro-citidin derivatives and pharmaceutical compositions containing them | |
| HUT43825A (en) | Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| HUT40453A (en) | Process for producing 11-beta-phenyl-gonanes and pharmaceutical compositions containing them | |
| HUT41772A (en) | Process for producing /4-substituted-piperazinyl- and -homopiperazinyl/-pyridazines and pharmaceutical compositions containing them | |
| DE3569245D1 (en) | Novel antibiotic nk84-0218 pharmaceutical compositions containing it and process for the production of the same | |
| HUT58304A (en) | Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them | |
| HUT47278A (en) | Process for producing pyrrolo-benzimidazols and pharmaceutical compositions containing them | |
| HUT48269A (en) | Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them | |
| HUT50121A (en) | Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them | |
| HUT47079A (en) | Process for producing n-amino-butyl-n-phenyl-aryl-amide derivatives and pharmaceutical compositions containing them | |
| HUT50473A (en) | Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds | |
| HU906358D0 (en) | Process for producing nukleosides and pharmaceutical compositions containing them | |
| IL86094A (en) | Crystalline human proinsulin, process for its production and pharmaceutical compositions containing it | |
| HUT43820A (en) | Process for producing n-(-2-((-2-hydroxy-phenyl-)(-phenyl-)-methylene-aminosquare )-ethyl-)-acetamide derivatives and pharmaceutical compositions containing them | |
| HUT48244A (en) | Process for producing isoxazol-3-carbolin derivatives and pharmaceutical compositions containing them | |
| HUT46692A (en) | Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them | |
| HUT54711A (en) | Process for producing peptide liguands binding irreverzible to bombezine-receptores and pharmaceutical compositions containing them | |
| HUT41762A (en) | Process for producing thieno-benzo-pyranes, -thiopyranes and naphtothiophenes and pharmaceutical compositions containing them | |
| GR870093B (en) | 8a- acylaminoergolines their production and pharmaceutical compositions containing them | |
| HUT46030A (en) | Process for producing citostatic antracyclin-glycoside derivatives and pharmaceutical compositions containing them | |
| HUT48591A (en) | Process for producing new fluoromethoxyphenyl-dihydro-pyridines and pharmaceutical compositions comprising these compounds |